Teva Asks High Court To Ax Fed. Circ. Claim Construction Rule

Teva Asks High Court To Ax Fed. Circ. Claim Construction Rule

Teva Pharmaceuticals USA Inc. urged the U.S. Supreme Court on Friday to reverse a Federal Circuit decision invalidating one of its patent for its multiple sclerosis drug Copaxone, claiming the appeals court has long overstepped its authority when it comes ...read more

  • Tags: